Stercia Adverse Reactions

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Warnings Special Precautions Use In Pregnancy & Lactation Adverse Reactions Caution For Usage Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Full Prescribing Info

Adverse Reactions

Clinical Studies for finasteride tablets 1 mg in the Treatment of Male Pattern Hair Loss: In three controlled clinical trials for finasteride tablets of 12-month duration, 1.4% of patients taking finasteride tablets (n=945) were discontinued due to adverse experiences that were considered to be possibly, probably or definitely drug-related (1.6% for placebo; n=934).
Clinical adverse experiences that were reported as possibly, probably or definitely drug-related in >1% of patients treated with finasteride tablets or placebo are presented in table as follows. (See Table 2.)

Click on icon to see table/diagram/image

View ADR Reporting Link

finasteride

Manufacturer:

Mega Lifesciences

Distributor:

Metro Drug